ImmunityBio, Inc.
IBRX NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 4, 2026
ET
EPS Est.
-0.08
EPS Actual
-0.22
Revenue Est.
$49.7M
Revenue Actual
$51.2M
Next Earnings Report
Date
Nov 3, 2026 · Tue
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
-0.08
Revenue Est.
$59.2M
Company Overview
ImmunityBio, Inc. (ticker IBRX) is listed on NASDAQ with a market cap of about $8.16B. Its next earnings report (FY2026 Q3) is expected on Nov 3, 2026 (ET), Pre-market, with consensus EPS of -0.08. In the last 15 reported quarters, EPS beat consensus estimates 5 times.
Actual EPS TrendRecently15Term · Mar 1, 2023 → Aug 4, 2026
Mar 1, 2023Range: -0.62 ~ -0.06Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | -0.08 | Below forecast↓-0.22 | $49.7M | $51.2M |
| May 7, 2026 | -- | -0.08 | Below forecast↓-0.62 | $43.1M | $44.2M |
| Feb 23, 2026 | -- | -0.08 | Above forecast↑-0.06 | $38.4M | $38.3M |
| Nov 4, 2025 | -- | -0.10 | Above forecast↑-0.07 | $37.8M | $32.1M |
| Aug 5, 2025 | -- | -0.10 | -0.10 | $31.9M | $26.4M |
| May 12, 2025 | -- | -0.12 | Below forecast↓-0.15 | $16.6M | $16.5M |
| Mar 3, 2025 | -- | -0.26 | Above forecast↑-0.09 | $9.6M | $7.6M |
| Nov 12, 2024 | -- | -0.18 | Above forecast↑-0.14 | $9.1M | $6.1M |
| Aug 12, 2024 | -- | -0.17 | Below forecast↓-0.20 | $2.5M | $1M |
| May 9, 2024 | -- | -0.16 | Below forecast↓-0.20 | $20000 | $40000 |
| Mar 19, 2024 | -- | -0.18 | Below forecast↓-0.36 | $25000 | $119500 |
| Nov 8, 2023 | -- | -0.27 | Above forecast↑-0.19 | $20000 | $82000 |
| Aug 8, 2023 | -- | -0.26 | -0.28 | $360000 | $41000 |
| May 11, 2023 | -- | -0.27 | -0.27 | $360000 | $360000 |
| Mar 1, 2023 | -- | -0.22 | Below forecast↓-0.27 | $25000 | $73000 |
Original Filings (SEC)
10-Q2026-08-04 ↗
8-K2026-08-04 ↗
8-K2026-07-30 ↗
8-K2026-06-10 ↗
8-K2026-05-18 ↗
10-Q2026-05-07 ↗
8-K2026-05-07 ↗
8-K2026-04-09 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
